Literature DB >> 26130971

Letters to the Editor.

Tarik Akar1, Gökhan Dindar1.   

Abstract

Year:  2015        PMID： 26130971      PMCID： PMC4482550     

Source DB:  PubMed          Journal:  Ochsner J        ISSN： 1524-5012


× No keyword cloud information.
  20 in total

1.  Disparate effects of metabolically healthy obesity in coronary heart disease and heart failure.

Authors:  Carl J Lavie; Richard V Milani; Hector O Ventura
Journal:  J Am Coll Cardiol       Date:  2013-12-15       Impact factor: 24.094

Review 2.  American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

Authors:  K Rajender Reddy; Kimberly L Beavers; Sarah P Hammond; Joseph K Lim; Yngve T Falck-Ytter
Journal:  Gastroenterology       Date:  2014-10-31       Impact factor: 22.682

3.  The obesity paradox, cardiorespiratory fitness, and coronary heart disease.

Authors:  Paul A McAuley; Enrique G Artero; Xuemei Sui; Duck-chul Lee; Timothy S Church; Carl J Lavie; Jonathan N Myers; Vanesa España-Romero; Steven N Blair
Journal:  Mayo Clin Proc       Date:  2012-04-12       Impact factor: 7.616

4.  The childhood obesity epidemic as a result of nongenetic evolution: the maternal resources hypothesis.

Authors:  Edward Archer
Journal:  Mayo Clin Proc       Date:  2014-11-17       Impact factor: 7.616

5.  Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

Authors:  Winnie Yeo; Tung C Chan; Nancy W Y Leung; Wai Y Lam; Frankie K F Mo; Miu Ting Chu; Henry L Y Chan; Edwin P Hui; Kenny I K Lei; Tony S K Mok; Paul K S Chan
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

6.  Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure.

Authors:  Carl J Lavie; Lawrence P Cahalin; Paul Chase; Jonathan Myers; Daniel Bensimhon; Mary Ann Peberdy; Euan Ashley; Erin West; Daniel E Forman; Marco Guazzi; Ross Arena
Journal:  Mayo Clin Proc       Date:  2013-02-27       Impact factor: 7.616

7.  Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat.

Authors:  Kalliopi Zachou; Alexandros Sarantopoulos; Nikolaos K Gatselis; Themistoklis Vassiliadis; Stella Gabeta; Aggelos Stefos; Asterios Saitis; Panagiota Boura; George N Dalekos
Journal:  World J Hepatol       Date:  2013-07-27

8.  The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy.

Authors:  Margherita Macera; Nicolina Capoluongo; Michele Gambardella; Mario Starace; Carmine Minichini; Mariantonietta Pisaturo; Giuseppe Pasquale; Nicola Coppola
Journal:  Antivir Ther       Date:  2014-08-08

9.  Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.

Authors:  Wai-Kay Seto; Thomas S Y Chan; Yu-Yan Hwang; Danny Ka-Ho Wong; James Fung; Kevin Sze-Hang Liu; Harinder Gill; Yuk-Fai Lam; Albert K W Lie; Ching-Lung Lai; Yok-Lam Kwong; Man-Fung Yuen
Journal:  J Clin Oncol       Date:  2014-10-06       Impact factor: 44.544

10.  The natural course of healthy obesity over 20 years.

Authors:  Joshua A Bell; Mark Hamer; Séverine Sabia; Archana Singh-Manoux; G David Batty; Mika Kivimaki
Journal:  J Am Coll Cardiol       Date:  2015-01-06       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.